Oxford Medical Simulation
United States
- Boston, Massachusetts
- 17/01/2024
- Series A
- $12,600,000
Oxford Medical Simulation delivers virtual reality medical simulation - training healthcare professionals to provide consistently world-class patient management without risking lives.
Medical simulation has become central to medical training and is highly effective. However, it is expensive, low throughput and not widely accessible. Healthcare workers therefore struggle to get the training they need to deliver optimal patient care.
We remove these barriers by offering virtual reality training scenarios. These provide a completely safe, controlled-stress learning environment for all healthcare professionals.
The focus is on clinical decision-making under pressure, crisis resource management, team interaction and patient engagement. Our fast-paced, repeatable, real-life scenarios can deliver consistently excellent, standardised clinical training to doctors and nurses to improve patient care.
- Industry Hospital & Health Care
- Website https://oxfordmedicalsimulation.com/
- LinkedIn https://www.linkedin.com/company/oxfordmedicalsimulation/about/
Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)